SEC Tracker
Get the app

Panacea Life Sciences Holdings

PLSH

Revenue $1.1M (+56%), diluted EPS −$0.09 in the quarter ended Mar 31, 2024, from a 10-Q filed .

Get email alertsGet the app
Legal name
Panacea Life Sciences Holdings, Inc.
CIK
1552189

SEC STAFF ACTION filed

SEC STAFF ACTION filing

Read the SEC STAFF ACTION on EDGARTables over time

Get an email when Panacea Life Sciences Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

All filings

Results, 8-Ks and Major or Notable filings come first, then registrations and share actions, then everything else, newest first. Routine filings are kept here unmarked; insider filings are summed up in one line.

Results, 8-Ks and key filings

  9. 33 older filings, Feb 14, 2023 to Dec 13, 2019
    13. 3 more 10-Q/A filings, Dec 20, 2021 to Dec 17, 2021

Financing and share filings

  2. 6 more 8-K filings, Mar 4, 2022 to Nov 3, 2020

Other filings

Older filings on EDGAR

Listing compliance

No listing notices in the 8-K item 3.01 filings SEC Tracker has read.

Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. All open notices

Trading halts

No trading halts for PLSH since Feb 22, 2019, when SEC Tracker began reading the Nasdaq Trader feed.

Halt times and codes from the Nasdaq Trader trade halts feed, which lists Nasdaq and other exchange halts. Filings matched by SEC Tracker from EDGAR by company and time. Not investment advice. All recent halts

Fails-to-deliver: 3,418 shares on Jul 8, 2026, per SEC data

Panacea Life Sciences Holdings shares and listing

From the company's own filings; each row names its source. Not investment advice.

  • Shares outstandingas of Jun 21, 2022 (10-K/A filed Jun 27)15Mwarrants, notes and options not read yet, so fully diluted is not known
  • Listing compliance8-K item 3.01No noticesin the filings read